awards grant

• A community based strength training program to improve work task performance in young adults with Down syndrome
• A new strategy to prevent anthracycline-induced cardiotoxicity while improving anti-cancer activity
• A novel and unique protein i-body for the treatment of chronic kidney disease through targeting CXCR4
• A randomised controlled trial of the safety and efficacy of N-Acetyl Cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence
• ADAM metalloprotease inhibition for treatment of colorectal cancer
• Activation of BMP4 signalling to inhibit breast cancer metastasis
• Advanced care planning in incurable cancer patients with disease progression on first line chemotherapy
• Alcohol and other drug treatment funding, purchasing and workforce: empirical analyses to inform policy
• Alcohol's harm to others: A cross-national study
• Alpha Particle Therapy of Solid Tumours
• Altering macrophage phenotype for the treatment of chronic airway disease and lung cancer
• An innovative treatment for first metatarsophalangeal joint osteoarthritis
• Anti-metastasis therapy via nanoparticle mediated drug delivery
• B cells and autoantibodies in the pathogenesis of hypertension
• Bcl-2 proteins in tumourigenesis
• Benefits and Costs of Home-based Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
• Better methods to collect self-report data on alcohol use behaviours from Aboriginal and Torres Strait Islander Australians
• Biomarkers of drug response in colon cancer
• Birthplace in Australia: A Prospective Cohort Study
• Brain and ovarian changes in mothers of children with Fragile-X mental retardation
• CASTLE (Candida and Staph Transmission: Longitudinal Evaluation) Study
• Calcium regulation in healthy and dystrophic skeletal muscle
• Calcium-dependent proteases in muscle damage and disease
• Calpain regulation in skeletal muscle
• Can shoe inserts reduce the burden of kneecap osteoarthritis?
• Cellular and Molecular Characterization of Erythroid Enucleation
• Characterising the role of IL-37 in the development of H. pylori infection
• Characterising the tumour suppressive function of myoepithelial cell stefin A in ductal carcinoma in situ
• Characterization of a Novel Epigenetic Boundary and Long Range Epigegetic Modifications Specific to FMR! Expansion Carriers with Behavioral and Cognitive Disorders - Implications for Earlier Diagnosis and Treatment.
• Circular RNAs: Trojan Horses of Oncogenesis
• Communication disabilities and patient safety in hospital
• Complement inhibitors for treatment of chronic inflammatory diseases
• Conologues: Ultra-fast-acting therapeutic insulins based on cone snail venom insulin principles
• Constraint Induced or Multi-Modal Aphasia Rehabilitation: An RCT for Stroke Related Chronic Aphasia.
• Control of gastrointestinal tumour progression by therapeutic interference with myeloid derived cells
• Cost-effective Development and Validation of Risk Prediction Models: Methods and Applications
• Craniofacial development in vertebrates
• Crystal methamphetamine use, sex and risk practice among gay and bisexual men
• Deciphering Tumour Heterogeneity of Breast Cancer Metastases using Barcoded Patient Derived Xenografts
• Deciphering the role of Scribble in Development and Disease
• Defining molecular pathways for COX2 maturation in mitochondrial Complex IV
• Defining the epigenetic origins of maternally inherited disease.
• Defining the molecular regulators of apoptotic cell disassembly and their role in cell clearance and lupus-like autoimmune disease
• Determining fundamental mechanisms compromised in Kir-linked disease states
• Determining the Role of Vitamin D in the Development of Asthma and Allergic Diseases in High Risk Families.
• Developing a New Treatment Method to Prevent Lymphopenia Associated with Sepsis
• Development of Antibiotics Targeting an Important Human Pathogen
• Development of better anticancer drugs
• Development of small molecules interfering with programmed cell death
• Diabetes antenatal milk expressing (DAME): a randomised controlled trial
• Diet as a therapeutic target in depression: A randomised controlled trial
• Dissecting the pathogenic triad of enteric pathogens: Assembly, structure and function of autotransporter proteases
• DsbA Inhibitors: from hits to leads
• DsbA foldases from multidrug resistant pathogens as targets for new antimicrobials
• Dual Targeting of Myc and Apoptosis Pathways for Improved Blood Cancer Treatment Outcomes
• ER Stress and Thymic Negative Selection
• Early HomeBase pulmonary rehabilitation after hospitalisation in chronic obstructive pulmonary disease
• Effectiveness of Occupational Therapy Homevisits to Improve Participation after Stroke
• Effects of podiatry on mobility and falls in older people
• Endometrial Exosomes: a New Paradigm in Endometrial-embryo Cross-talk
• Evaluating Acceptance and Commitment Therapy as a psychological treatment for schizophrenia
• Evolutionary conservation of mechanisms regulating cell death
• Exosomes as Mediators of Metastasis
• Exploiting the cross talk between Tuft cells and group 2 innate lymphoid cells for tissue homeostasis and disease
• Exploring the role of Arrcd4 in extracellular vesicle biogenesis and its implications in tissue homeostasis
• Femoroacetabular impingement and early arthritis
• Footwear for osteoarthritis of the big toe joint
• Four-food elimination diet and disease mechanisms in children with eosinophilic oesophagitis
• Function and Molecular Mechanism of Histidine-rich Glycoprotein in Necrotic Cell and Pathogen Clearance
• Functional Analysis of the Toxoplasma Myosin Driving Tissue Dissemination and Host Cell Invasion.
• Functional Resolution of PTEX, the Exporter of Virulence Factors in Malaria Parasites
• GPER pharmacotherapy in acute stroke
• General Practice Optimising Structured MOnitoring To Improve Clinical outcomes in Type 2 Diabetes: GP-OSMOTIC T2D
• Genetic validation of Stat3 as a tractable pharmacological target ingastrointestinal disease
• Healing the Past by Nurturing the Future: Learning how to identify and support Indigenous parents who have experienced childhood trauma
• How AP-1 regulates genes mediating colorectal cancer progression
• How do anti-cancer drugs kill tumour cells
• How do small extracellular vesicles contribute to the development of prion disease
• How language develops, what goes wrong, and why it matters: Following the Early Language in Victoria Study to age 13.
• I-ACT: Phase I trial of Amnion Cell Therapy for Ischaemic Stroke to establish the maximum tolerable dose
• Identifying factors that improve the health of prisoners who inject drugs
• Identifying, validating and exploiting a novel dclk1-positive bipotential lung stem cell
• Immune Responses that Dictate Metastatic Spread in Breast Cancer
• Improving Detection and management of dEmentia in older Aboriginal and Torres Strait Islanders attending Primary Care (IDEA-PC)
• Improving arm function after stroke using task specific training
• Improving mobility after traumatic brain injury using ballistic strength training
• Increasing the use of long-acting reversible contraception: The Australian Contraceptive ChOice pRoject (ACCORd)
• Inflammasomes and Interleukin-18 Signalling: Novel Biomarkers And Therapeutic Targets For Kidney Disease
• Inhibition of malaria by targeting functional areas on AMA1
• Innovative patient education for preventing falls after hospital discharge
• Investigation of the role of the DUSP5 gene in colon cancer
• Magnocellular delay and autistic behaviour
• Maximising health potential through enhancement of movement behaviours from early life
• Mechanism of anoxic iron acquisition in pathogenic bacteria
• Mechanisms involved in skeletal muscle contraction in health, exercise and disease
• Mediator Kinase as a Therapeutic Target for Wnt/β-catenin Dependent Malignancies
• Molecular Basis of Ca2+-Dependent Disruption of EC-coupling and Weakness in Skeletal Muscle
• Molecular imaging and therapy of solid tumours
• Motor Neurone Disease: Patient centred care for a progressive neurological disease - evidence driving policy
• Novel Dual Domain Targeting Strategies against ErbB Receptors
• Novel Therapeutics for Colon Cancer Treatment
• One-on-one midwifery care for women at low risk of medical complications: a randomised controlled trial
• Optimising Rehabilitation Outcomes in Frail Older Adults. Mobility in Older People
• Optimising Upper Limb Recovery following Stroke: A Randomised ControlledTtrial of the Effects of Botulinum Toxin-A Combined with Intensive Rehabilitation Compared to Botulinum Toxin-A  Alone
• Outdoor aeroallergen exposure and asthma exacerbations
• Performance monitoring dysfunction in ageing
• Perinatal exposure to household and environmental toxins and the risk of asthma and allergic disease up to 25 years
• Personally Controlled Electronic Health Records: Charting the course for successful healthcare transitions in young adults with communication disabilities
• Physiological and Pathological Effects of Oxidation on Contractile Function in Skeletal Muscle
• Prenatal Genomic Testing
• Preventing Child Internalising Problems: Follow up of a Population-based Randomised Trial through Middle Childhood.
• Preventing early anxiety disorders
• Preventing postnatal depression in new mothers using telephone peer support: a randomised controlled trial
• Prevention of postnatal mental health problems in women
• Promoting protective feeding practices to prevent childhood obesity: follow up of a successful obesity prevention program commencing in infancy
• Protein Disulphide Isomerase and Motor Neuron Disease
• Reappraisal of the mechanisms underlying implantation success or failure
• Regulation of calcium entry in healthy and dystrophic muscle
• Regulation of cell signalling and tumourigenesis by Lgl
• Regulation of protein synthesis in muscle
• Role of Kaposi sarcoma herpesvirus in tumour development
• Scabies mite intestinal proteases as targets for novel therapeutics.
• Stem Cells from the testis
• Strength training for adolescents and young people with cerebral palsy
• Supplemental Oxygen in Pulmonary Rehabilitation Trial (SuppORT)
• Targeting Cell Death Pathways in Malignant Mesothelioma
• Targeting aldosterone receptors in cerebrovascular disease
• Targeting cell death pathways in cancer
• Targeting of G-CSF in combination with standard therapy for advanced breast cancer
• Targeting oxidant-dependent pathways to treat skeletal muscle wasting in COPD
• The Australian Longitudinal Study of Health and Relationships
• The FGFR family as therapeutic targets in gastric cancer and predictive biomarkers of response to regorafenib.
• The Molecular Basis for Manganese Uptake by Pathogenic Bacteria
• The Role of Natural Protein Inhibitors in Blocking Breast Cancer Invasion
• The alternate day fasting diet in adolescents with obesity: a randomised controlled trial
• The effects of different alcohol pricing policies on alcohol consumption, health, social and economic outcomes, and health inequality in Australia
• The interplay between viperin, peroxisomes and the cellular innate antiviral response
• The metastability of proteome foldedness in neurodegenerative disease
• The role of heparanase in inflammation
• The role of the asymmetry gene GPSM2 in breast cancer
• Therapy to reduce falling in Parkinsons
• Towards a national sports safety strategy - addressing facilitators and barriers towards safety guideline uptake
• Transcriptional Effectors of Oncogenic ERK Signalling in Colorectal Cancer
• Understanding the genesis of cognitive deficits in Alzheimers disease
• Using chromosome rearrangements as tumour-specific markers for disease monitoring in lung cancer using droplet digita PCR
• Viral strategies to prevent host cell death
• Women's Evaluation of Abuse and Violence Care in general practice